Moderna, Inc.MRNA
Market cap
$12.7B
P/E ratio
| Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Net product sales | - | - | - | - | - | 6,671 | 3,109 |
| Other revenue | - | - | - | - | - | 177 | 127 |
| Total revenue | - | - | - | - | - | 6,848 | 3,236 |
| Cost of sales | - | - | 8 | 2,617 | 5,416 | 4,693 | 1,464 |
| Research and development | 454 | 496 | 1,370 | 1,991 | 3,295 | 4,845 | 4,543 |
| General and Administrative Expense | 94 | 110 | 188 | 567 | 1,132 | 1,549 | 1,174 |
| Total operating expenses | - | - | 1,567 | 5,175 | 9,843 | 11,087 | 7,181 |
| (Loss) income from operations | -413 | -546 | -763 | 13,296 | 9,420 | -4,239 | -3,945 |
| Interest income | 27 | 39 | 25 | 18 | 200 | 421 | 425 |
| Other expense, net | 2 | -8 | -6 | -29 | -45 | -124 | -87 |
| (Loss) income before income taxes | - | - | - | 13,285 | 9,575 | -3,942 | -3,607 |
| Income Tax Expense (Benefit) | 0 | -1 | 3 | 1,083 | 1,213 | 772 | -46 |
| Net (loss) income | -385 | -514 | -747 | 12,202 | 8,362 | -4,714 | -3,561 |
| Basic (in usd per share) | - | - | - | 30.31 | 21.26 | -12.33 | -9.28 |
| Diluted (in usd per share) | - | - | - | 28.29 | 20.12 | -12.33 | -9.28 |